Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Gene Therapy
  • Research Article
  • Published:

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

Gene Therapyvolume 9, pages291–296 (2002)Cite this article

Abstract

A major obstacle in cancer gene therapy is selective tumor delivery. Previous studies have suggested that genetically engineered anaerobes of the genus Clostridium might be gene therapy vectors because of their ability to proliferate selectively in the hypoxic/necrotic regions common to solid tumors. However, the tumor colonization efficiency of the strain previously used was insufficient to produce any antitumor effect. Here we describe for the first time the successful transformation of C. sporogenes, a clostridial strain with the highest reported tumor colonization efficiency, with the E. coli cytosine deaminase (CD) gene and show that systemically injected spores of these bacteria express CD only in the tumor. This enzyme can convert the nontoxic prodrug 5-fluorocytosine (5-FC) to the anticancer drug 5-fluorouracil (5-FU). Furthermore, systemic delivery of 5-FC into mice previously injected with CD-transformed spores of C. sporogenes produced greater antitumor effect than maximally tolerated doses of 5-FU. Since most human solid tumors have hypoxic and necrotic areas this vector system has considerable promise for tumor-selective gene therapy.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscribe to this journal

Receive 6 print issues and online access

￥40,000 per year

only ￥6,667 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Minton N.P.et al. Chemotherapeutic tumour targeting using clostridial sporesFEMS Microbiol Rev 199517: 357 357

    Article CAS PubMed  Google Scholar 

  2. Fox M.E.et al. Anaerobic bacteria as a delivery system for cancer gene therapy: activation of 5-fluorocytosine by genetically engineered clostridiaGene Therapy 19963: 173 173

    CAS PubMed  Google Scholar 

  3. Lemmon M.L.et al. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironmentGene Therapy 19974: 791 791

    Article CAS PubMed  Google Scholar 

  4. Malmgren R.A., Flanigan C.C. . Localization of the vegetative form ofClostridium tetani in mouse tumors following intravenous spore administrationCancer Res 195515: 473 473

    CAS PubMed  Google Scholar 

  5. Möse J.R., Möse G. . Onkolyseversuche mit apathogenen anaeroben Sporenbildern am Ehrlich Tumor des MausZ Krebsforsch 195963: 63 63

    Article  Google Scholar 

  6. Möse J.R., Möse G. . Oncolysis by clostridia. I. Activity ofClostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinomaCancer Res 196424: 212 212

    Google Scholar 

  7. Thiele E.H., Arison R.N., Boxer G.E. . Oncolysis by clostridia. III. Effects of clostridia and chemotherapeutic agents on rodent tumorsCancer Res 19642: 222 222

    Google Scholar 

  8. Engelbart K., Gericke D. . Oncolysis by clostridia V. Transplanted tumors of the hamsterCancer Res 195424: 239 239

    Google Scholar 

  9. Carey R.W.et al. Clostridial oncolysis in manEur J Cancer 19673: 37 37

    Article  Google Scholar 

  10. Heppner F., Mose J.R. . The liquefaction (oncolysis) of malignant gliomas by a non-pathogenic clostridiumActa Neurol 197812: 123 123

    Google Scholar 

  11. Heppner F., Mose J., Ascher P.W., Walter G. . Oncolysis of malignant gliomas of the brain13th Int Cong Chemother 1983226: 38 38

    Google Scholar 

  12. Kievit E.et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenograftsCancer Res 199959: 1417 1417

    CAS PubMed  Google Scholar 

  13. Lawrence T.S.et al. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosineCancer Res 199858: 2588 2588

    CAS PubMed  Google Scholar 

  14. Krasnykh V.et al. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacityCancer Res 200060: 6784 6784

    CAS PubMed  Google Scholar 

  15. Xu L.et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenograftsHum Gene Ther 199910: 2941 2941

    Article CAS PubMed  Google Scholar 

  16. Pawelek J.M., Low K.B., Bermudes D. . Tumor-targeted Salmonella as a novel anticancer vectorCancer Res 199757: 4537 4537

    CAS PubMed  Google Scholar 

  17. Low K.B.et al. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targetingin vivoNat Biotechnol 199917: 37 37

    Article CAS PubMed  Google Scholar 

  18. Fabricius E.M.et al. Quantitative investigations into the elimination ofin vitro-obtained spores of the non-pathogenicClostridium butyricum strain CNRZ 528, and their persistence in organs of different species following intravenous spore administrationRes Microbiol 1993144: 741 741

    Article CAS PubMed  Google Scholar 

  19. Gericke D.et al. Further progress with oncolysis due to apathogenic clostridiaZentralbl Bakteriol 1979243: 102 102

    CAS  Google Scholar 

  20. Streilein J.W. . Unraveling immune privilegeScience 1995270: 1158 1158

    Article CAS PubMed  Google Scholar 

  21. Hirst D.G., Brown J.M., Hazlehurst J.L. . Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gainBr J Cancer 198246: 109 109

    Article CAS PubMed PubMed Central  Google Scholar 

  22. Minton N.P.et al. Clostridial cloning vectors Woods DR (eds);The Clostridia and Biotechnology Butterworth-Heinemann 1993 pp 119–150

  23. Oultram J.D.et al. Introduction of plasmids into whole cells ofClostridium acetobutylicum by electroporationFEMS Microbiol Letts 198856: 83 83

    Article CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by USPHS grant CA 64697 awarded to JMB from the US National Cancer Institute and funds to NPM from the UK Department of Health.

Author information

Authors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA

    S-C Liu, AJ Giaccia & JM Brown

  2. Center for Applied Microbiology and Research, Porton Down, Salisbury, UK

    NP Minton

Authors
  1. S-C Liu

    You can also search for this author inPubMed Google Scholar

  2. NP Minton

    You can also search for this author inPubMed Google Scholar

  3. AJ Giaccia

    You can also search for this author inPubMed Google Scholar

  4. JM Brown

    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Liu, SC., Minton, N., Giaccia, A.et al. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis.Gene Ther9, 291–296 (2002). https://doi.org/10.1038/sj.gt.3301659

Download citation

Keywords

This article is cited by

Access through your institution
Buy or subscribe

Advertisement

Search

Advanced search

Quick links

[8]ページ先頭
©2009-2025 Movatter.jp